Migraines & headaches Board decisions

The Board remands the issues of service connection for various conditions and an increased rating for migraine headaches due to inadequate medical opinions.

The Board denied the veteran's claims for increased ratings and service connection, finding that the evidence did not support a higher rating or service connection.

The Board granted a 50 percent evaluation for migraine headaches since December 1, 2022, and denied an evaluation in excess of 30 percent prior to that date. The Board also remanded the claim for a total disability evaluation based upon individual unemployability due to service-connected disabilities.

The Board denied the Veteran's appeal for an earlier effective date for a TDIU and remanded several service connection claims.

The Board denied an initial compensable rating for migraines and remanded the claims for service connection for an acquired psychiatric disorder and bilateral pes planus.

The Board granted service connection for migraines, resolving reasonable doubt in favor of the Veteran.

The Board remands the veteran's claims for service connection for various conditions, including bilateral flatfoot, left and right ankle, elbow, hip, and migraine conditions, to obtain new VA medical examinations.

The Board granted a rating of 50 percent for service-connected migraines and a rating of 100 percent for service-connected PTSD and major depressive disorder, as well as special monthly compensation at the housebound rate.

The appeal for increased ratings for degenerative joint disease of the left ankle and erectile dysfunction was withdrawn by the Veteran, resulting in their dismissal. The claims for allergic rhinitis, lumbar spine degenerative disc disease, gastroesophageal reflux disease, and migraine headaches are remanded for further development.

The Board denied the Veteran's claim for an earlier effective date for the 70 percent rating for his service-connected psychiatric disability, finding that May 9, 2022, was the earliest date as of which it was factually ascertainable based on all evidence of record that an increase in disability had occurred.

The Board denied service connection for allergic rhinitis and chronic fatigue syndrome, denied an initial compensable rating for bilateral hearing loss disability, denied increased ratings in excess of 30 percent for chronic sinusitis, granted a 50 percent initial rating for tension headaches, and denied initial compensable ratings for dermatitis and respiratory disability (shortness of breath).

The Board granted service connection for obstructive sleep apnea as aggravated by sinusitis and tension headaches as aggravated by adjustment disorder with mixed anxiety and depressed mood.

The Board granted an earlier effective date of April 27, 2022 for the assignment of a 10 percent rating for service-connected migraine headaches.

The appeal for entitlement to a total disability rating based on individual unemployability (TDIU) is dismissed as moot due to the Veteran's 100 percent combined rating assigned for his service-connected disabilities.

The Board granted a 50 percent disability rating for the Veteran's service-connected migraine headaches, resolving reasonable doubt in favor of the Veteran.

The Board remands the claims for initial ratings higher than the assigned percentages for service-connected conditions, including migraine headaches, bilateral carpal tunnel syndrome, lumbosacral strain, and bilateral lower extremity radiculopathy.

The Board granted a 30 percent rating for the Veteran's service-connected headaches from November 17, 2021 to December 7, 2021, but denied ratings in excess of 30 percent and prior to that date.

The Board granted service connection for a left knee disability and a 70 percent rating, but no higher, prior to June 11, 2018 for PTSD. The TDIU claim was denied.

The Board denied the veteran's claims for an initial compensable rating for erectile disorder, headaches, and service connection for chronic fatigue syndrome (CFS), chest pain, bilateral leg conditions, and somatic symptom disorder.

The Board granted an effective date of September 11, 2023 for a 50 percent rating for migraine headaches.